Intervention

Stereotactic body radiotherapy

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 12 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials12
Recruiting2
Common conditions25
Lead sponsors shown12
Advertisement

Clinical trials

12 shown
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast CancerNCT05534438 · 2022-09-06
RECRUITING
5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)NCT04610372 · 2021-07-12
RECRUITING
STereotactic Body Radiotherapy (SBRT) for Oligoprogressive Breast CancerNCT06489821 · 2024-09-01
NOT_YET_RECRUITING
Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)NCT06251492 · 2024-01-30
UNKNOWN
Combining ICI With SBRT or HypoFrx-RT for ES NSCLCNCT05451173 · 2023-10-09
UNKNOWN
Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid TumorsNCT05915481 · 2023-06-21
UNKNOWN
Checkpoint Inhibitors and SBRT for MCRPCNCT05655715 · 2019-11-25
COMPLETED
Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung CancerNCT03574220 · 2019-02-19
WITHDRAWN
Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast CancerNCT03750396 · 2018-08-01
UNKNOWN
SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung EffectsNCT03383302 · 2018-02-08
COMPLETED
A Study of SBRT in Combination With rhGM-CSF for Stage IV NSCLC Patients Who Failed in Second-line ChemotherapyNCT02623595 · 2016-05-01
WITHDRAWN
Evaluation of the Immunological Effects of a Combined Treatment With Radiation and Cyclophosphamide in Metastasized Breast Cancer PatientsNCT02441270 · 2015-04-01
WITHDRAWN

Common conditions

Trial status mix

UNKNOWN4
WITHDRAWN3
COMPLETED2
RECRUITING2
NOT_YET_RECRUITING1

Phase mix

PHASE28
PHASE13
EARLY_PHASE12
NA2
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.